We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to ...

In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other oversold pharma stocks to buy according to analysts. On February 20, Emily Field ...

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price was down 4.7% during mid-day trading on Monday after an insider sold shares in the company. The stock traded as low as $45.16 and ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Shares of NASDAQ CRSP opened at $44.51 on Wednesday. CRISPR Therapeutics AG has a 12 month low of $36.52 and a 12 month high of $90.62. The company has a market cap of $3.82 billion, a P/E ratio ...

In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other oversold pharma stocks to buy according to analysts. On February 20, Emily Field ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CRISPR Therapeutics (CRSP -11.4%), Editas Medicine (EDIT -7.2%) and Intellia Therapeutics (NTLA -6.6%) are all down on the heels of two studies published in Nature Medicine that... BySeeking Alpha ...